Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteotropic beta-cyclodextrin for local bone regeneration.

Xin-Ming Liu1, Andrew T Wiswall, John E Rutledge

  • 1Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, 986025 Nebraska Medical Center, COP 3026, Omaha, NE 68198-6025, USA.

Biomaterials
|January 18, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protocol for a randomized controlled trial to compare bone-loading exercises with risedronate for preventing bone loss in osteopenic postmenopausal women.

BMC women's health·2016
Same author

Combined exposure to big endothelin-1 and mechanical loading in bovine sternal cores promotes osteogenesis.

Bone·2016
Same author

Palatal anesthesia: comparison of four techniques for decreasing injection discomfort.

Northwest dentistry·2014
Same author

A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.

Bone·2013
Same author

N-acetylcysteine increases the frequency of bone marrow pro-B/pre-B cells, but does not reverse cigarette smoking-induced loss of this subset.

PloS one·2011
Same author

Biological constraints that limit compensation of a common skeletal trait variant lead to inequivalence of tibial function among healthy young adults.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2011
Same journal

Remodeling TME via feedback-driven photothermal-ferroptosis-immune cascade.

Biomaterials·2026
Same journal

Corrigendum to "Photodynamic therapy produces enhanced efficacy of antitumor immunotherapy by simultaneously inducing intratumoral release of sorafenib" [Biomaterials 2020, 240, 119845].

Biomaterials·2026
Same journal

Mg-integrated octopus-inspired hydrogel dressing enables autonomous adhesion and wound closure for enhanced healing via sequential microenvironment regulation.

Biomaterials·2026
Same journal

Engineering miRNA-223 nanocomplexes via bioorthogonal self-assembly for precision therapy of intervertebral disc degeneration.

Biomaterials·2026
Same journal

Corrigendum to "Enhanced fluorescence imaging guided photodynamic therapy of sinoporphyrin sodium loaded graphene oxide" [Biomaterials 42 (2015) 16442].

Biomaterials·2026
Same journal

An injectable Ce-MnCo LDH nanozyme gel with cascade catalytic activity for acute radiation proctitis in rats.

Biomaterials·2026
See all related articles

Alendronate-beta-cyclodextrin conjugate (ALN-beta-CD) enhances bone formation, independent of prostaglandin E(1) (PGE(1)). ALN-beta-CD alone stimulates significant new bone growth, suggesting a novel anabolic mechanism for skeletal diseases.

Area of Science:

  • Biomaterials Science
  • Bone Biology
  • Drug Delivery Systems

Background:

  • Alendronate-beta-cyclodextrin conjugate (ALN-beta-CD) is an osteotropic agent designed for skeletal disease treatment.
  • The conjugate exhibits strong binding to hydroxyapatite (HA), the primary component of bone.
  • ALN-beta-CD can form inclusion complexes with prostaglandin E(1) (PGE(1)), a known bone anabolic agent.

Purpose of the Study:

  • To evaluate the bone-targeting delivery system ALN-beta-CD for skeletal disease treatment.
  • To investigate the bone anabolic potential of ALN-beta-CD, both alone and complexed with PGE(1).
  • To elucidate the mechanism behind the observed bone anabolic effects.

Main Methods:

  • Preparation and characterization of ALN-beta-CD.

Related Experiment Videos

  • Formation of ALN-beta-CD/PGE(1) molecular complex.
  • In vivo studies using a bilateral rat mandible model.
  • Histomorphometry and micro-CT evaluation of bone formation.

    • Main Results:

    • ALN-beta-CD/PGE(1) complex demonstrated strong local bone anabolic reaction in rats.
    • ALN-beta-CD alone also exhibited significant bone anabolic effects.
    • ALN-beta-CD induced more new bone formation than its complex with PGE(1).
    • Alendronate (ALN) injection showed peripheral new bone formation; PGE(1), saline, and ethanol had no anabolic effect.
    • Micro-CT confirmed the anabolic effects of ALN-beta-CD.

    Conclusions:

    • The bone anabolic effect of ALN-beta-CD is independent of PGE(1) or mechanical stimuli.
    • ALN-beta-CD itself acts as a potent bone anabolic agent.
    • Further research is needed to fully understand the working mechanism of ALN-beta-CD.